Verastem (VSTM) Cash from Investing Activities Growth (3y) (2014 - 2026)
Verastem (VSTM) Cash from Investing Activities Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | -29.84% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 38.24% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -22.09% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Verastem | 607.94 Mn | 410.11 Mn | 15.90 Mn | -171.08% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -171.08% |
| Dec 31, 2025 | -28.12% |
| Jun 30, 2024 | 129.68% |
| Mar 31, 2024 | 65.14% |
| Dec 31, 2023 | 29.20% |
| Sep 30, 2023 | -2,168.88% |
| Jun 30, 2023 | 704.41% |
| Mar 31, 2023 | -26.52% |
| Dec 31, 2022 | -19.67% |
| Sep 30, 2022 | -35.84% |
| Jun 30, 2022 | -14.34% |
| Mar 31, 2022 | 275.79% |
| Dec 31, 2021 | 26.00% |
| Sep 30, 2021 | 38.31% |
| Jun 30, 2021 | 86.77% |
| Mar 31, 2021 | -68.56% |
| Dec 31, 2020 | -169.64% |
| Sep 30, 2020 | -26.00% |
| Jun 30, 2020 | -26.03% |
| Mar 31, 2020 | 98.53% |